Market Wire - UCB Announces FDA Filing for lacosamide in the Treatment of Diabetic Neuropathic Pain

Published on: Thu, 29 Nov 2007 08:00:00 GMT

November 29, 2007 -- U.S. Food and Drug Administration (FDA) has accepted for filing theNew Drug Application (NDA) for the use of Vimpat(TM) (lacosamide) inthe treatment... More »